We are live on ! Find out more
NIP

Nicholas Investment Partners Portfolio holdings

AUM $1.39B
1-Year Est. Return 97.11%
This Fund
S&P 500
This Quarter Est. Return
+25.16%
1 Year Est. Return
+97.11%
3 Year Est. Return
+361.61%
5 Year Est. Return
+496.81%
10 Year Est. Return
+3,647.83%
AUM
$1.46B
AUM Growth
+$147M
Cap. Flow
-$82.7M
Cap. Flow %
-5.66%
Top 10 Hldgs %
25.13%
Holding
215
New
28
Increased
57
Reduced
41
Closed
25

Top Buys

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$31.1M
2
MRK icon
Merck
MRK
+$27.8M
3
MIRM icon
Mirum Pharmaceuticals
MIRM
+$24.3M
4
IMGN
Immunogen Inc
IMGN
+$14.5M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$14.1M

Top Sells

Rank Stock Value
1
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$29.3M
2
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$28.4M
3
UTHR icon
United Therapeutics
UTHR
+$26.8M
4
SRPT icon
Sarepta Therapeutics
SRPT
+$25.8M
5
PODD icon
Insulet
PODD
+$23.6M

Sector Composition

Rank Sector Weight
1 Healthcare 53.92%
2 Technology 13.34%
3 Industrials 8.74%
4 Consumer Discretionary 4.85%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELF icon
76
e.l.f. Beauty
ELF
$5.81B
$4.74M 0.32%
41,501
-9,199
-18% -$885K
JPM icon
77
JPMorgan Chase
JPM
$950B
$4.64M 0.32%
31,897
+6,174
+24% +$849K
CR icon
78
Crane Co
CR
$12.7B
$4.54M 0.31%
+50,998
New +$3.94M
BAH icon
79
Booz Allen Hamilton
BAH
$9.15B
$4.34M 0.3%
38,862
– –
ODFL icon
80
Old Dominion Freight Line
ODFL
$44.9B
$4.29M 0.29%
23,200
– –
APPF icon
81
AppFolio
APPF
$7.04B
$4.2M 0.29%
+24,423
New +$3.56M
BKR icon
82
Baker Hughes
BKR
$61.1B
$4.2M 0.29%
132,877
-60,498
-31% -$1.76M
CPA icon
83
Copa Holdings
CPA
$5.8B
$4.18M 0.29%
37,845
+3,374
+10% +$338K
HCP
84
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$4.13M 0.28%
157,573
+80,624
+105% +$2.36M
BOX icon
85
Box
BOX
$4.6B
$4.03M 0.28%
137,001
+40,250
+42% +$1.11M
VC icon
86
Visteon
VC
$2.78B
$3.97M 0.27%
27,666
– –
COTY icon
87
Coty
COTY
$2.48B
$3.91M 0.27%
318,493
+9,456
+3% +$112K
SKT icon
88
Tanger
SKT
$4.52B
$3.89M 0.27%
+176,251
New +$3.53M
GTES icon
89
Gates Industrial Corporation Ltd.
GTES
$7.15B
$3.88M 0.27%
287,519
+158,142
+122% +$2.05M
CCJ icon
90
Cameco
CCJ
$42.4B
$3.82M 0.26%
121,949
+15,963
+15% +$449K
FWONK icon
91
Liberty Media Series C
FWONK
$25.8B
$3.58M 0.24%
49,189
+23,988
+95% +$1.71M
FSS icon
92
Federal Signal
FSS
$7.83B
$3.47M 0.24%
+54,133
New +$2.99M
SMAR
93
DELISTED
Smartsheet Inc.
SMAR
$3.44M 0.24%
89,880
+9,982
+12% +$432K
ASML icon
94
ASML
ASML
$669B
$3.4M 0.23%
4,697
– –
ERII icon
95
Energy Recovery
ERII
$443M
$3.33M 0.23%
119,062
+145
+0.1% +$3.62K
CP icon
96
Canadian Pacific Kansas City
CP
$80.5B
$3.32M 0.23%
41,154
– –
GS icon
97
Goldman Sachs
GS
$303B
$3.23M 0.22%
10,000
– –
DHI icon
98
D.R. Horton
DHI
$42.3B
$2.99M 0.2%
24,554
-2,294
-9% -$251K
EG icon
99
Everest Group
EG
$14.4B
$2.9M 0.2%
8,492
+246
+3% +$88.8K
ACLS icon
100
Axcelis
ACLS
$4.33B
$2.72M 0.19%
+14,826
New +$2.13M
2 3
4
5 6

Similar funds

FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
1CP
1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
TA
Trivest Advisors Hong Kong $1.39B AUM 273.03% 1-Year Est. Return
AU
Algebris (UK) London, United Kingdom $1.38B AUM 3.87% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
BCP
Blue Chip Partners Farmington Hills, Michigan $1.39B AUM 22.32% 1-Year Est. Return

Nicholas Investment Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Nicholas Investment Partners held 215 positions worth $1.46B, up 11% from $1.32B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Nicholas Investment Partners withdrew a net $82.7M in Q2 2023, closing 25 positions and reducing 41 holdings. Its most notable exit was Prometheus Biosciences, Inc. Common Stock, an estimated $29.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 53% a quarter earlier, followed by Technology and Industrials.

Against the trend, Nicholas Investment Partners opened a new position in Intra-Cellular Therapies Inc. worth $31.6M.

  • Nicholas Investment Partners's largest Q2 2023 buy was Intra-Cellular Therapies Inc.: 499,503 shares worth $31.6M.
  • Nicholas Investment Partners added most to Xenon Pharmaceuticals in Q2 2023, an estimated $14.1M increase.
  • Nicholas Investment Partners's biggest Q2 2023 reduction was Lantheus, cutting an estimated $9.72M.
  • Nicholas Investment Partners fully exited Prometheus Biosciences, Inc. Common Stock in Q2 2023, selling an estimated $29.3M.
  • Nicholas Investment Partners's ten largest holdings make up 25% of its $1.46B portfolio in Q2 2023.
  • Nicholas Investment Partners opened 28 new positions and closed 25 in Q2 2023.
  • Nicholas Investment Partners's portfolio value rose 11% quarter-over-quarter to $1.46B.

Based on Nicholas Investment Partners's 13F filing for Q2 2023, filed 10 Aug 2023.